🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12496+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12496 recruiting trials

Enrolling by InvitationNCT06634004

Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya

👨‍⚕️ Manus J Donahue, MBA, PhD, Vanderbilt University Medical Center📍 2 sites📅 Started Sep 2023View details ↗
NARecruitingNCT06605794

FreeFlow Percutaneous Atrial Septal Shunt for IPAH

👨‍⚕️ Junbo GE, Prof., Fudan University📍 1 site📅 Started Sep 2023View details ↗
NARecruitingNCT05871892

18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

🏥 University of Aarhus📍 1 site📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT05968690

Naltrexone and Propranolol Combined With Immunotherapy

👨‍⚕️ Sarah Weiss, MD, Rutgers Cancer Institute of New Jersey📍 1 site📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT05877430

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

🏥 CJ Bioscience, Inc.📍 4 sites📅 Started Sep 2023View details ↗
NARecruitingNCT06651996

Adherence and Feasibility of Remote Rehabilitation for Chronic Patellofemoral Joint Pain: a Randomized Controlled Trial

🏥 Peking University Third Hospital📍 1 site📅 Started Sep 2023View details ↗
Enrolling by InvitationNCT06019364

Transfusion of Whole Blood in Acute Bleeding

👨‍⚕️ Sofia Ramström, Ass. Prof, Örebro University, Sweden📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT06111625

Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL

🏥 Sichuan University📍 1 site📅 Started Sep 2023View details ↗
NARecruitingNCT06000865

Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE

👨‍⚕️ Allen Cheong, PhD, The Hong Kong Polytechnic University📍 1 site📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT05722938

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

👨‍⚕️ Ricard Ferrer Roca, Dr., Hospital Vall d'Hebron📍 146 sites📅 Started Sep 2023View details ↗
NARecruitingNCT06042140

Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair

👨‍⚕️ Ramesha Papanna, MD, MPH, The University of Texas Health Science Center, Houston📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06060041

IC-8 Apthera IOL New Enrollment Post Approval Study

🏥 Bausch & Lomb Incorporated📍 14 sites📅 Started Sep 2023View details ↗
NARecruitingNCT06037941

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

👨‍⚕️ Gaetano Rocco, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Sep 2023View details ↗
NARecruitingNCT05763251

Comparison of Uncomplicated Candidemia Therapy Duration in Children

👨‍⚕️ Brian Fisher, DO, Children's Hospital of Philadelphia📍 17 sites📅 Started Sep 2023View details ↗
RecruitingNCT05263830

Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy

👨‍⚕️ Manon ALLAIRE, Dr, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT05908084

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

🏥 Humacyte, Inc.📍 32 sites📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT06051617

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

👨‍⚕️ Gilead Study Director, Gilead Sciences📍 178 sites📅 Started Sep 2023View details ↗
NARecruitingNCT05820919

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

👨‍⚕️ Lynn Snow, PhD, The University of Alabama📍 3 sites📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT06056336

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

👨‍⚕️ Changqing Pan, the International Committee of Medical Journal Editors📍 1 site📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT06006390

CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors

👨‍⚕️ Qi Mei, M.D, Shanxi Bethune Hospital/Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology📍 3 sites📅 Started Sep 2023View details ↗
← PreviousPage 378 of 625Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →